Highlights for June 2016:
- Zydus acquires two ANDAs from Teva, strengthens its US portfolio
- Royal Philips seeks to make one acquisition in India over next one year
- Dr Reddy’s to acquire product portfolio of 8 ANDAs from TEVA in the US for USD 350 Mn
- Torrent Pharma acquires manufacturing Unit of Glochem for ~USD 45 Mn.
- Cancer Genetics Inc. partners with Sayre Therapeutics
- Cipla inks pact with Russian firm Nacimbio for antiretroviral drugs
- Zydus Cadila and Eczac?ba?? enter into a strategic collaboration to market biosimilars in Turkey
- Boston Scientific to make India biggest product development hub outside the US.
- India’s BioEconomy crosses $35 billion : ABLE Report
For more such news and updates, please join our Group "Global Life Science Business in India" on LinkedIn.
Aagami Updates:
- Aagami completes BIO International Convention 2016 with over 40 promising one to one meetings.
- Aagami completed a highly successful 4 city business trip in India along with a US based plant biotechnology company.
- Aagami Inc. and Rosen Biosciences organized an event on 02 June at the Illinois Science + Technology Park, Skokie, Illinois. This event provided an overview of the Indian Pharma and Biotech Market and opportunities for Life science companies based in Illinois.